Results 1 to 10 of about 11,769,643 (158)

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults [PDF]

open access: yesScientific Reports
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic tryptamine. Plants containing 5-MeO-DMT have been used throughout history, and in recent years both synthetic and toad-derived 5-MeO-DMT use is being increasingly reported ...
Raphaël Millière   +2 more
exaly   +9 more sources

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study [PDF]

open access: yesFrontiers in Psychiatry, 2023
Psychedelic therapy is, arguably, the next frontier in psychiatry. It offers a radical alternative to longstanding, mainstays of treatment, while exciting a paradigm shift in translational science and drug discovery.
Anya Ragnhildstveit   +19 more
doaj   +14 more sources

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study [PDF]

open access: yesFrontiers in Psychology, 2018
5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those ...
Joseph Barsuglia   +13 more
doaj   +7 more sources

Vigilance state dissociation induced by 5-MeO-DMT in mice [PDF]

open access: yesCommunications Biology
Psychedelics lead to profound changes in subjective experience and behaviour, which are typically conceptualised in psychological terms rather than corresponding to an altered brain state or a distinct state of vigilance.
Benjamin J. B. Bréant   +7 more
doaj   +6 more sources

5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats [PDF]

open access: yesScientific Reports
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent classical psychedelic known to induce changes in locomotion, behaviour, and sleep in rodents. However, there is limited knowledge regarding its acute neurophysiological effects.
Katarina E Leão   +2 more
exaly   +5 more sources

A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2018
The subgranular zone (SGZ) of dentate gyrus (DG) is one of the few regions in which neurogenesis is maintained throughout adulthood. It is believed that newborn neurons in this region encode temporal information about partially overlapping contextual ...
Rafael Vitor Lima da Cruz   +4 more
doaj   +6 more sources

Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants [PDF]

open access: yesArchives of Razi Institute, 2023
Since depression is a common mental illness affecting an estimated 5% of people worldwide, investigators are encouraged to develop effective antidepressants.
Kalirajan Rajagopal   +5 more
doaj   +2 more sources

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT [PDF]

open access: yesFrontiers in Psychology
A three-item Peak Experience Scale (PES) was developed to rapidly evaluate the strength of the psychoactive experience, and to guide the dosing regimen, of the psychedelic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT; mebufotenin).
Johannes T. Reckweg   +5 more
doaj   +2 more sources

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind [PDF]

open access: yesBiomedicines
In recent years, psychopharmacology has experienced a significant challenge, highlighting a renewed and strong scientific interest in psychedelics as breakthrough therapies for mental disorders.
Alice Melani   +9 more
doaj   +2 more sources

Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT1A Receptor for Therapeutic Potential in Depression and Anxiety [PDF]

open access: yesResearch
The 5-HT1A receptor is a critical target in the treatment of depression and anxiety. Bufotenine derivatives, such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), 5-hydroxy-N,N-dimethyltryptamine (5-OH-DMT), and 5-hydroxy-N,N,N-dimethyltryptamine—derived
Shu-jie Li   +16 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy